THRDThird Harmonic Bio, Inc.

Nasdaq thirdharmonicbio.com


$ 11.59 $ 0.21 (1.85 %)    

Thursday, 02-May-2024 15:59:41 EDT
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 11.59
$ 11.40
$ 0.00 x 0
$ 0.00 x 0
$ 11.40 - $ 11.59
$ 4.31 - $ 12.42
89,392
na
459.49M
$ 0.67
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-29-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 third-harmonic-bio-q4-eps-017-beats-031-estimate

Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(...

 third-harmonic-bio-fy23-eps-078-vs-245-yoy

Summary of Financial ResultsCash Position: Cash and cash equivalents totaled $269.1 million as of December 31, 2023. Based on t...

 third-harmonic-bio-appoints-christopher-murphy-as-chief-financial-and-business-officer-and-provides-business-update

Chris brings extensive enterprise-level leadership experience in business development, commercial operations, and corporate str...

 third-harmonic-bio-q3-eps-061-misses-027-estimate

Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of ...

 third-harmonic-bio-inc-files-for-mixed-shelf-of-up-to-400m

-SEC Filing

 morgan-stanley-maintains-equal-weight-on-third-harmonic-bio-raises-price-target-to-7

Morgan Stanley analyst Michael Ulz maintains Third Harmonic Bio (NASDAQ:THRD) with a Equal-Weight and raises the price targe...

 third-harmonic-bio-announces-q2-2023-financial-results-financial-position-with-cash-and-cash-equivalents-totaling-2781m-as-of-june-30-2023

Summary of Financial Results Cash Position: Cash and cash equivalents totaled $278.1 million as of June 30, 2023. Based on the...

 third-harmonic-bio-announces-next-generation-oral-kit-inhibitor-product-candidate-thb335

THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribut...

 correction-third-harmonic-bio-q1-eps-081-misses-035-estimate

Third Harmonic Bio (NASDAQ:THRD) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of ...

 third-harmonic-bio-q1-eps-081-misses-035-estimate

Third Harmonic Bio (NASDAQ: THRD) reported quarterly losses of $(0.81) per share which missed the analyst consensus estimate of...

 top-5-health-care-stocks-that-may-rally

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 5-cheapest-health-care-stocks-you-should-think-about

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 5-cheapest-health-care-stocks-you-should-think-about

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 top-5-health-care-stocks-that-may-surge

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 152 stocks made new 52-week lows.

 morgan-stanley-downgrades-third-harmonic-bio-to-equal-weight-lowers-price-target-to-5

Morgan Stanley analyst Michael Ulz downgrades Third Harmonic Bio (NASDAQ:THRD) from Overweight to Equal-Weight and lowers th...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION